During the process of drug discovery, INPHARMA can be used to derive the structure of receptor/lead compound complexes binding to each other with a K d in the lM to mM range. To be successful, the methodology needs adjustment of various parameters that depend on the physical constants of the binding event and on the receptor size. Here we present a thorough theoretical analysis of the INPHARMA interligand NOE effect in dependence of experimental parameters and physical constants. This analysis helps the experimentalist to choose the correct experimental parameters and consequentially to achieve optimal performance of the methodology.
Introduction
In structure-based drug design a three-dimensional picture of the binding mode of known ligands to the target macromolecule is essential to the elaboration of a high affinity drug. When the complex cannot be crystallized, NMR can be used to obtain structural information in solution. However, the determination of a high resolution structure of the complex by NMR in solution is often limited by the availability and the physical properties of the target, which in many cases is either too large to be observed by NMR, too insoluble or not available with the necessary 13 C/ 15 N/ 2 D labeling from expression systems.
For ligands that bind weakly to the target (K d in the lM range) detailed structural information on the ligand bound conformation can be obtained by transferred-NOEs and transferred-CCR rates [1] [2] [3] [4] [5] [6] . This approach requires small quantities of unlabeled target (1-10 lM solution) and an excess of ligand, is applicable to any complex independently of the size of the target macromolecule and does not require any isotope labeling scheme. However, as the resonances of the target macromolecule are not observed, the methodology does not provide any structural information on the geometry of the intermolecular interactions in the complex. Models of the ligand binding mode can be obtained from the apo-structure of the target macromolecule and the bound structure of the ligand by docking calculations. The docking models are ranked on the basis of the computed intermolecular interaction energy or with respect to experimental information, such as the ligand binding epitope, obtained by the STD or WATER-LOGSY approaches [7] [8] [9] [10] . However, this process mostly results in multiple models for the complex structure due to the lack of site-specific structural information.
To overcome this problem, we developed the INPHARMA methodology (Interligand Noes for PHARmacophore MApping) that allows mapping the structure of the binding pocket of a macromolecule on the NMR resonances of two competitively binding ligands [11] [12] [13] [14] . The method is based on the observation of interligand, spin-diffusion mediated, transferred-NOE data, between two ligands L 1 and L 2 , binding competitively and weakly to a macromolecular receptor T (Fig. 1) . During the mixing time of the NOESY experiment, L 1 binds to the receptor and its protons ðH L 1 sÞ transfer their magnetization to the receptor protons (H T s). During the same mixing time of the NOESY experiment L 1 dissociates from the receptor and L 2 binds. The magnetization that was transferred from H L 1 to H T can now be transferred from H T to H L 2 . This leads to an intermolecular peak between H L 1 and H L 2 although L 1 and L 2 have never been close in space at any time during the NMR experiments. The NOE peak between H L 1 and H L 2 is a spin-diffusion mediated effect via the receptor proton H T . Clearly this effect can only occur if H L 1 and H L 2 are both close to the proton H T in the two complexes TL 1 and TL 2 , respectively. A number of such interligand NOEs define the relative orientation of the two ligands in the receptor binding pocket. The INPHARMA methodology belongs to the class of ligand-detected approaches (where the resonances of the target macromolecule are not seen in the spectrum), like transferredNOEs, transferred-CCR rates, STD and others [1, 2, 5, 7, 15] . The binding pocket of the target macromolecule is here indirectly mapped on the resonances of the two ligands. Due to the nature of the magnetization transfer, the information gained in the INPHARMA spectrum is highly site-specific, in contrast to STD or WATER-LOGSY experiments [8] , which can only identify the face of the ligand that is solvent exposed with respect to that in contact with the receptor. The INPHARMA NOEs are used to rank and select binding modes of L 1 and L 2 obtained by docking the bound conformation of the ligands to a structural model of the apo-receptor. The direct employment of the INPHARMA NOEs in structure calculation programs (X-PLOR) is currently under development in our laboratories.
The method was originally developed to derive the binding mode of L 2 when the binding mode of L 1 is known. However, we have recently demonstrated that the INPHARMA approach is much more powerful and allows in favorable cases the de novo description of the binding mode of both L 1 and L 2 [11, 12] . In this work we have shown that the methodology is precise enough to unambiguously select one docking mode per ligand and accurate enough to select the correct docking mode, as compared to the crystal structures available for the investigated test cases [12] .
Here we present a thorough theoretical analysis of the INPHAR-MA interligand NOE effects. We use simple model systems to describe the effect of various parameters, such as receptor proton density, NOESY mixing time, ligand concentrations, etc., on the size of the observed INPHARMA NOEs. Furthermore, we present a comprehensive description of the applicability of the INPHARMA approach. We provide all tools necessary to predict the size of the INPHARMA NOEs expected for complexes with different K d and k off values and to choose the best conditions, in terms of sample composition and experimental NMR parameters, for the observation of INPHARMA NOEs of respectable size. The theoretical data presented here are essential to ensure that the powerful INPHARMA method can be widely applied by non-NMR experts in the process of drug development.
Material and methods

The model systems
The system that can be investigated with the INPHARMA method consists of a macromolecular receptor, usually a protein, and two competitively binding ligands. In this theoretical investigation we use simplified model systems to describe the influence of various structural parameters, such as intermolecular proton distances, proton densities in the receptor, depth of the binding pocket, etc., on the expected INPHARMA NOEs. Two simple geometries are used: (i) linear model: the ligands and the receptor consist of protons disposed in a linear arrangement with a fixed intra-molecular inter-proton distance d. The ligands contain from 1 to 3 protons (Fig. 2A); (ii) cubic model: the ligands consist of two or three protons linearly arranged with an inter-proton distance d; the receptor is a cube of different size (5 3 À 9
3
). In the receptor/ligand complex the protons are located at the nodes of a three-dimensional lattice with unit length d in all three dimensions (Fig. 2B ). In the free receptor, the nodes of the binding pocket are empty. The ligands insert perpendicular to one face, in the middle of it, so that the last atom is part of this face.
Theory
Intensities of NOE cross-peaks of a receptor/ligand complex in exchange with the free forms of both the ligand and the receptor are described by the following equation:
with a solution of the form: where K and R are the kinetic and relaxation matrices, M(0) the initial magnetization, M 0 the equilibrium magnetization and s m the mixing time. Two different models have been considered for the chemical exchange. The first is a three-step model, including the state where both ligands and the receptor are found also in the free form, as described by:
In the second model, we assume that the receptor is never in the unbound state, due to presence of the two ligands in large excess. This model is described by:
The relaxation matrix is a diagonal block matrix, where each submatrix describes the proton-proton relaxation pathway of one species; the species present in solution are the two ligands in the free state L 1 , L 2 , the two complexes TL 1 and TL 2 of the target macromolecule and L 1 or L 2 , respectively [16] , and the free target macromolecule T. 
The kinetic matrix is built according to the equations that rule the chemical equilibrium:
and has the form:
where I is the identity matrix of the same size as the corresponding block matrix in R.
Model 2
Compared to the matrix for model 1, the relaxation matrix R for model 2 lacks the last block representing the unbound target macromolecule.
The kinetics matrix K is derived from the equations:
The elements of the kinetics matrices of the two models are derived from the binding constants and the equilibrium concentrations. The last are calculated from the mass conservation laws.
Model 2:
Individual elements of the relaxation matrix have the following form:
Á ðJð0Þ þ 3JðxÞ þ 6Jð2xÞÞ
where q i is the longitudinal relaxation rate of proton H i , r ij is the cross-relaxation rate of protons H i and H j , d ij is the distance between protons H i and H j in the same chemical species (ligand, target macromolecule or complex) and ''A" stand for the chemical species. All protons H j are considered in the calculation of the relaxation rates q i and r ij, irrespectively of the value of d ij .
Analytical solution for a three spins system
A description of the transferred-NOE effect for a two-spin system has been given in great detail [5, [17] [18] [19] . In these studies the receptor was not included in the calculation, namely it was assumed that it does not contribute considerably to the process of magnetization transfer between the ligand protons. However, it has been reported that the contribution of the receptor cannot be neglected for an accurate prediction of transferred-NOEs [16, [20] [21] [22] [23] [24] . Clearly, for the calculation of the INPHARMA NOEs, the receptor protons must be taken into account as they mediate the transfer of magnetization between the two ligands. An analytical solution that describes the INPHARMA NOE transfer cannot be systematically found for a three spin system, where the two ligands L 1 and L 2 and the receptor T consist of one proton each, as this would correspond to searching for an analytical solution of a polynomial equation of sixth order [25] . However, an analytical description of the INPHARMA transfer can be found by making two crude approximations: (1) the concentrations of the ligands and the receptor are equal; (2) all four species L 1 , L 2 , TL 1 and TL 2 have the same auto-relaxation rates q and the cross-correlated relaxation rate r between the H T and H L protons in TL 1 and TL 2 are equal. Furthermore, the affinity of the two ligands is also chosen to be equal.
The first two approximations are clearly not realistic. However, an ''easy-to-read" analytical solution for the three-spin system, even under the two coarse approximations made above, is still useful to describe at a glance the overall dependence of the INPHAR-MA magnetization transfer on internal dynamics and correlation time.
In the next section we show results calculated numerically for realistic scenarios with real physical constants and for multi-spin systems.
Under the approximations mentioned above, the relaxation matrix and the kinetics matrix simplify to the following form:
where k = k 12 = k 21 . Solving Eq. (1) implies finding six eigenvalues that satisfy:
The INPHARMA NOE S(t) between L 1 and L 2 is defined by:
where a i are coefficients that fulfilled the following equation system:
as described in Ref. [26] . The solution can be calculated from the known determinant of the Vandermonde matrix of Eq. (17):
Even with the drastic approximations made for this model system, the solution turns out to be quite complicated. However, a straightforward formula is obtained for the asymptotic development of the variable k towards very high values ( Fig. 3 ) and lead to the canonical expression of the INPHARMA NOE:
This expression is reminiscent of the well known dependence of transferred-NOEs intensities on the mixing time t of the NOESY experiment: 
However, while the transferred-NOEs intensities depend on the time t according to the hyperbolic sine function, which can be approximated to a linear function at small mixing times, the INPHARMA NOEs show a hyperbolic cosine dependence on time, which can be approximated by a parabolic curve at short mixing times. This behavior reveals the spin-diffusion nature of the INPHARMA NOEs, which depend quadratically on rt.
The formula in Eq. (19) can be used to visualize the influence of the correlation time and internal motions on the build-up of the INPHARMA NOE. The effect of internal motions is estimated using the Lipari-Szabo's model-free approach in the limit of a very fast internal correlation time.
where S is the order parameter varying from 0 to 1 and assuming equal order parameters for the auto-relaxation rate q and the cross-relaxation rate r.
In Fig. 3, we show 
For S 2 6 1, the cross-relaxation rate r is slower resulting in a delayed build-up of the INPHARMA NOEs. As for the transferred-NOEs, the presence of an order parameter S -1 has a differently strong effect on the INPHARMA NOE depending on the mixing time. At 1 s mixing time the difference is negligible while at 400 ms, there is a factor of four between the INPHARMA NOE assuming S 2 = 1 and S 2 = 0.5 (full line and dashed-dotted line in Fig. 3 ). This difference has to be taken in account in the interpretation of the INPHARMA NOE peaks that are transferred by highly dynamic parts of the binding pocket. Efforts to include order parameters in the interpretation of the data are on-going in our laboratories.
Numerical solution for a multi-spin system
For more than three spins and for systems with realistic parameters, the equations system becomes too complex to search for an analytical solution. Therefore a numerical solution is calculated in Matlab for the linear and cubic model systems assuming both model 1 and model 2 for the chemical exchange and in dependence of physical parameters such as s c , s m , k off , species concentrations and internal dynamics. The results of such simulations, which are essential to understand the influence of the physical and experimental parameters on the size of the observed INPHARMA NOEs, are presented in the following section.
Results and discussion
Choice of the kinetic model
One of the challenges of the INPHARMA method is to handle a large number of docking models for each of the two ligands, which need to be ranked with respect to the measured interligand NOEs. Thus, the calculation time needed to predict the interligand NOEs for one pair of models should be kept to a minimum. A medium size protein (20 (Fig. 4A) . However, for tighter binding ligands with K d = 10 lM or lower, the presence of the free receptor (0.5 lM) can be safely neglected, as the error on the interligand NOE is less than 3-5% over the complete range of mixing times from 0 s to 1 s (Fig. 4B) . In our experience errors smaller than 5-10% are not expected to influence the outcome of the analysis. 
Dependence on the k off of the two ligands
In order to observe the INPHARMA NOEs, the two ligands should bind weakly to the receptor, namely they should exchange a few times between their free and bound states during the mixing time of a NOESY experiment. Fig. 5 ) the INPHARMA NOE has reached its maximum value, while for a k off of 100 Hz the INPHAR-MA NOE has an observable size equal to about two third of its maximum value. These results indicate that the transfer of magnetization between the two ligands improves with the number of exchange events in the binding pocket of the receptor. The condition on the k off is not too stringent and the INPHARMA NOE could be observed for most weakly binding ligands, typically available in an early phase of drug development, which we tested.
More critical is the relative size of the dissociation rates for L 1 and L 2 , k 1off and k 2off . Clearly, the optimal situation for the receptor mediated transfer of magnetization between the two ligands is when k 1off = k 2off and the two ligands spend an equal amount of time in the receptor bound state. Fig. 6 shows the efficiency of the INPHARMA NOE transfer when k 1off /k 2off -1. A considerable amount of magnetization transfer through the INPHARMA NOE is obtained for a k 1off /k 2off value of up to 8, while for k 1off /k 2off = 16 the INPHARMA NOE is less than 1% at a mixing time of 1 s and has decreased by a factor of 4 at 500 ms with respect to k 1off = k 2off . Thus, the method requires that the affinity of the two ligands is of comparable size.
An obvious way to compensate for the different affinity of the two ligands, and consequently for the different equilibrium concentrations of the TL 1 and TL 2 complexes in solution, might seem that of adjusting the concentration of the two ligands, as for example using [ (Fig. 7) . However, at longer mixing times the optimal concentration changes due to the contribution of additional pathways of magnetization transfer and spin-diffusion inside the receptor. The use of longer mixing times renders the analysis of the INPHARMA NOE intensity more difficult, due to the contribution of many spin-diffusion pathways; on the other hand long mixing times are necessary to increase the intensity of the INPHARMA signal.
For a complex with s c = 20 ns the optimal value is found around (Fig. 7B) . On the other hand for a complex with s c = 200 ns (Fig. 7C) = 0.81) despite the differences in the k off . In this case it is more important to achieve fast transfer of magnetization between the two ligands away from the fast relaxing receptor, in order to avoid the diffusion of the ligands magnetization in the receptor, rather than to have similar population of the TL 1 and TL 2 complexes. 
Influence of proton density
An important question is how the number of protons of both the ligands and the receptor influences the INPHARMA NOEs. Clearly, the most efficient transfer is obtained when the magnetization is not allowed to diffuse away through undesired spin-diffusion pathways and only the desired spin-diffusion transfer L 1 ? receptor ? L 2 occurs. In a real system, however, this is never the case, due to the presence of protons in the ligands and in the receptor that do not belong to the binding epitope or to the binding pocket.
We first investigate the effect of the ligand proton density by comparing the INPHARMA NOE in a linear system, as in Fig. 2A , for the case when the two ligands consist of only one, two or three protons (Fig. 8 ). The presence of protons H 2 of L 1 and L 2 diminishes the efficiency of the transfer between H 1 of L 1 and H 1 of L 2 by a factor of three (Fig. 8B) , due to the fact that the ligand protons H 2 compete with the receptor protons for the H 1 magnetization. However, the presence of additional ligand protons at d P 5 Å (H 3 of L 1 and L 2 ) does not further affect the efficiency of the INPHARMA NOE.
Due to the dependence of spin-diffusion on the size of the molecule, proton density on the large receptor is likely to have a stronger effect on the intensity of the INPHARMA NOE. To simulate the dependence of the INPHARMA NOE on the number of protons of the receptor, while keeping the s cT constant, we used the artificial cubic system of Fig. 2B. Fig. 9 shows the results of such simulations for a cube of size ranging from 5 3 to 9 3 . As expected, the efficiency of magnetization transfer diminishes upon increasing the number of receptor protons, due to the undesired diffusion of the ligand(s) magnetization from the binding pocket to the receptor body. INPHARMA NOE shows a parabolic dependence on s m , which is typical of a second order effect (spin-diffusion) (see also Eq. (21)). Increasing the correlation time increases the steepness of the initial part of the curve.
As it is seen in Fig. 10B , for a receptor of 400 kDa or larger, the maximum INPHARMA NOE is obtained for s m < 100 ms, while for a receptor of ca. 20 kDa, mixing times of the order of 500 ms or higher can be used. In our experience the best results, in terms of selection of the correct docking mode by comparison of the theoretical and experimental INPHARMA NOEs, are obtained when the experimental data are acquired at mixing times for which the INPHAR-MA NOE has not yet reached its maximum value. This is due to the fact that in this regime only ''short" spin-diffusion pathways contribute to the signal, thus minimizing the errors made by neglecting internal motions in the calculation of the theoretical NOEs (vide infra). In fact, the more receptor protons contribute to the spin-diffusion transferred-NOEs, the largest is the error made by neglecting their internal dynamics.
Dependence on receptor concentration
Clearly the size of the INPHARMA NOE depends not only on the s c of the receptor, the affinity of the ligands to the receptor and the kinetic constants but also on the concentration of the species in solution. In Fig. 11 we show a contour plot of the intensity of the INPHARMA NOE in dependence of the mixing time (x axis) and the fraction of bound ligand (y axis), defined as
The ligands total concentration is 500 lM each.
At short mixing times the INPHARMA NOE intensity linearly increases with the fraction of bound ligand. On the other hand, at long mixing times the intensity of the INPHARMA NOE steeply depends on the fraction of bound ligand. For s m > 600 ms the optimal value of the INPHARMA NOE is achieved for a fraction of bound ligand ranging from 0.02 to 0.06, whereas at 150 ms bound ligand fractions ranging from 0.1 to 0.35 are required for optimal signal. However, the best results can be obtained at long mixing times using a low fraction of bound ligand (Fig. 11 ).
Effect of internal dynamics
Dynamics plays an important role in the NOE transfer mechanisms. Campbell and Sykes evaluated the influence of internal motions of the bound and free ligand on the transferred-NOE effect neglecting the receptor protons [27] . Here, we analyze the effect of internal motions on the interligand INPHARMA NOE effect using the model-free approach of Lipari and Szabo [28] . Clearly in this analysis we need to consider the receptor protons as well, as they mediate the transfer of magnetization between the two ligands. In order to quantitatively evaluate the error made by neglecting internal dynamics in the back-calculation of the INPHARMA NOE from a certain docking model, we performed theoretical simulations of the INPHARMA NOE, using the cubic system of Fig. 2B , in presence of internal dynamics of variable amplitude. First we assumed the same order parameter S 2 for all protons in all species, both free and bound. Fig. 12 shows that the efficiency of the INPHARMA transfer decreases in presence of internal dynamics. At low mixing times the decrease of the magnetization transfer efficiency is proportional to S 4 , as it was found in the analytical solution of Eq. (21) . Thus the effect of internal motions at low mixing times corresponds to decreasing the correlation time of the species by a factor S 4 (Fig. 12B) .
The best choice of the mixing time depends not only on the s c of the complex but also on the presence of internal motions. The optimal compromise between optimizing the intensities of the INPHARMA NOEs and minimizing the error generating from neglecting internal motions is achieved, in our experience, by acquiring the experimental data at mixing times for which the INPHARMA NOEs have not reached their maximum value, yet. In a more realistic system, different internal dynamics occurs for each species. Therefore, we simulated the efficiency of the INPHARMA magnetization transfer using three different order parameters S 2 L , S 2 T and S 2 TL , for the free ligands protons, the free receptor protons and the receptor protons or ligand protons in the complexes, respectively (Fig. 13) . Our simulations show that the INPHARMA magnetization transfer is not considerably affected either by the internal dynamics of the free ligands or by that of the free receptor (provided that the concentration of the free receptor is not too high). On the other hand, internal dynamics in the complexes measurably affects the efficiency of the INPHARMA magnetization transfer. For a medium size receptor, the efficiency of magnetization transfer at constant s m decreases upon increasing the amplitude of internal dynamics either for the receptor or the ligands protons in the complex, whereby the effect of receptor protons dynamics is smaller. The reason for this lies in the two counteracting effects of the internal dynamics of the receptor protons: on the one hand, receptor protons dynamics reduces the spin-diffusion rate necessary for the INPHARMA transfer, thus resulting in smaller INPHARMA NOEs; on the other hand it reduces the rate of diffusion of the magnetization away from the binding pocket into the receptor body, thus improving the efficiency of the INPHARMA magnetization transfer.
Conclusions
The INPHARMA method is a flexible, rapid and powerful technique to determine the relative, and in some favorable cases even the absolute, orientations of two ligands binding weakly and competitively to the same binding pocket of a common receptor. This methodology is particularly useful in the process of optimizing drug leads as it provides a fast method to determine the relative orientation of different chemical skeletons in the receptor binding pocket.
Here we provide a theoretical description of the INPHARMA effect and we describe its dependence on both kinetic and experi- mental variables. The equations and the graphs shown here provide an arsenal of tools to determine the applicability of the method to specific cases and to correctly choose the experimental parameters. We show that the choice of the experimental parameters, as for example the s m of the NOESY experiments, is critical and strictly depends on the system under investigation. Furthermore, we provide an estimation of the errors committed by using approximations, as for example neglecting the effect of internal motions.
The analysis presented here helps to optimize the results from INPHARMA measurements.
